![Jeffrey Hackman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Hackman
Verkställande Direktör på
FENNEC PHARMACEUTICALS INC.
Förmögenhet: 818 830 $ per 2026-08-31
Profil
Jeffrey S Hackman is currently the Chairman & Chief Executive Officer at Comera Life Sciences, Inc. and the Chief Executive Officer & Director at Fennec Pharmaceuticals, Inc. Previously, he held positions as the Chairman, President & Chief Executive Officer at Comera Life Sciences Holdings, Inc., Chief Operating Officer & Director at Leadiant Biosciences, Inc., Chief Operating Officer & Director at Sigma-tau Healthscience USA, Inc., SVP-US Internal Medicine & Oncology franchise at Shire Plc, Vice President & Head-North America Region at Baxalta US, Inc., and Chief Executive & Operating Officer, Executive VP at Novelion Therapeutics, Inc. He obtained his undergraduate degree from Lycoming College.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-08-31 | 66 302 ( 0,19 % ) | 818 830 $ | 2026-08-31 |
Aktiva positioner av Jeffrey Hackman
| Företag | Position | Start |
|---|---|---|
| FENNEC PHARMACEUTICALS INC. | Verkställande Direktör | 2024-08-16 |
Comera Life Sciences, Inc.
 Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic medicines | Verkställande Direktör | 2021-09-08 |
Tidigare kända positioner av Jeffrey Hackman
| Företag | Position | Slut |
|---|---|---|
| COMERA LIFE SCIENCES HOLDINGS, INC. | Verkställande Direktör | 2024-01-31 |
| NOVELION THERAPEUTICS INC. | Verkställande Direktör | 2018-11-20 |
Sigma-tau Healthscience USA, Inc.
 Sigma-tau Healthscience USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparation | Verksamhetschef | - |
Baxalta US, Inc.
 Baxalta US, Inc. BiotechnologyHealth Technology Engages in the research, development, and manufacture of biopharmaceutical products | Företagsledare/Principal | - |
| SHIRE | Företagsledare/Principal | - |
Jeffrey Hackmans utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
41
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Fennec Pharmaceuticals, Inc.
 Fennec Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutic products which dedicated to improving the lives of children with cancer who experience hearing loss | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Lycoming College
 Lycoming College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for rare diseases | Health Technology |
Baxalta US, Inc.
Baxalta US, Inc. BiotechnologyHealth Technology Engages in the research, development, and manufacture of biopharmaceutical products | Health Technology |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets rare disease products, metreleptin and lomitapide | Health Technology |
Sigma-tau Healthscience USA, Inc.
Sigma-tau Healthscience USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparation | Health Technology |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic medicines | Health Technology |
Comera Life Sciences Holdings, Inc.
 Comera Life Sciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
